ESM1 and acute lymphoblastic leukemia: A recent case-control study was conducted in 100 childhood ALL survivors and 80 healthy age- and sex-matched children as a control group, to assess the endothelial dysfunction in ALL survivors using a new serum endothelial-specific molecule, i.e., endocan.